unknown
Stage
2020
Founded
2
Investors
About
BioHive develops skin organoid models derived from induced pluripotent stem cells (iPSCs) for toxicity and efficacy testing in the cosmetic and pharmaceutical industries, providing advanced in vitro solutions that reduce reliance on animal testing.
Explore BioHive's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.